Anixa Biosciences Inc
ANIX
Nasdaq
Manufacturing
Chemicals
$2.70
▼
$0.03
(-1.10%)
Mkt Cap: 90.53 M
Price
$2.70
Mkt Cap
90.53 M
Day Range
$2.62 — $2.74
52-Week Range
$2.44 — $5.46
Volume
49,476
Open $2.71
50D / 200D Avg
$2.86
5.69% below
50D / 200D Avg
$3.40
20.59% below
Price History
Financial Trends
No fundamental snapshot available yet.
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Revenue | — | 210,000.0 | 210,000.0 | 512,500.0 | 250,000.0 |
| Net Income | -10.93 M | -12.55 M | -9.81 M | -13.60 M | -10.02 M |
| EPS (Diluted) | -0.34 | -0.39 | 0.32 | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -11.70 M | -13.83 M | -11.01 M | -13.88 M | -9.98 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 5.07 M | 6.40 M | 4.77 M | 6.70 M | 4.38 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Income Tax | — | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 16.08 M | 21.59 M | 25.52 M | 30.41 M | 9.45 M |
| Total Liabilities | 2.13 M | 2.70 M | 2.15 M | 2.21 M | — |
| Shareholders' Equity | 15.16 M | 20.00 M | 24.34 M | 29.05 M | 8.76 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 1.24 M | 1.27 M | 915,000.0 | 12.36 M | 6.42 M |
| Current Assets | 15.89 M | 21.36 M | 25.36 M | 30.20 M | 9.37 M |
| Current Liabilities | 1.97 M | 2.50 M | 2.03 M | 2.04 M | 1.19 M |
{"event":"ticker_viewed","properties":{"ticker":"ANIX","listing_kind":"stock","pathname":"/stocks/anix","exchange":"Nasdaq","country":"US"}}